The biopharma industry still has work to do on LGBTQ+ inclusion — inside companies and in research. Trans healthcare is a political target, civil rights are on tenuous grounds, and yet LGBTQ+ professionals continue driving change at biotech startups, Big Pharma, and beyond.
For the fourth year, Endpoints is spotlighting the leaders making it happen. Join us virtually to hear from the 2026 honorees on where the community stands today.
